Addressing TB prevention, treatment among migrant populations

NewsGuard 100/100 Score
Jan 30 2012

In this post on USAID's "IMPACTblog," Christina Lau, USAID health officer for Central Asia, discusses tackling tuberculosis (TB) in migrant populations, writing, "Most migrants are unable to access the health care system because they are undocumented laborers, who lack proper identification documents required for health care treatment, and who fear deportation if their documentation status becomes known." She notes, "USAID is working in coalition with government and international partners in order to improve access to TB services and treatment for this crucial population" (1/26).

Print

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Disease/Infection News

    Tags: , ,

    Comments (0)

    Suggested Reading

    Enzymatic cocktail emerges as new hope against mycobacterial infections
    The path to a better tuberculosis vaccine runs through Montana
    More than 80% of patients with tuberculosis do not have persistent cough, study shows
    Harnessing immune enhancement to combat drug-resistant tuberculosis
    Immune cells in overdrive: Study finds unbalanced response worsens lung infections
    New classification of tuberculosis aims to improve focus on the early stages of disease
    Study reveals BCG vaccine's unexpected role in fighting influenza
    Revvity unveils a new era of automated tuberculosis testing

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines